Our Technology

Accelerating Excellence

MicroNetTM, a built-in precision mesh, traps and seals unstable thrombus and plaque to prevent embolization.

Our Products

Superior Performance

Our next generation Carotid Embolic Prevention System, CGuardTM, helps physicians treat CAS patients.

Our Data

Proven Superiority

The MGuardTM EPS demonstrated superior perfusion over standard stents for STEMI patients in the MASTER trial.


12-08-2019 - ICI Meeting

Tel Aviv, Israel, December 8-10, 2019

11-19-2019 - VEITH Symposium 2019

New York, USA

Read more >

Welcome to InspireMD

Solutions that Save Lives. Innovation that Inspires.

InspireMD is dedicated to the development of advanced technologies, including MicroNetTM (see Our Technology), which is transforming the future of vascular procedures.

InspireMD launched its newest innovation, the CGuard Embolic Prevention System, in early 2015. For more information on CGuardTM and the CARENET clinical trial, please visit our News page.


MGuardTM,  MGuard PrimeTM and CGuardTM are CE Mark approved. They are not approved for sale in the U.S.A.